HEG1通过调控稳定血流诱导的内皮KLF2/4表达发挥抗动脉粥样硬化作用
本研究重新分析小鼠部分颈动脉结扎模型的单细胞RNA测序数据,发现HEG1是稳定血流诱导基因。通过内皮特异性敲除小鼠及人主动脉内皮细胞实验,证实HEG1通过KRIT1和MEKK3-MEK5-ERK5-MEF2通路调控稳定血流诱导的KLF2/4表达,从而抑制单核细胞黏附、通透性和迁移;HEG1缺失加重高胆固醇血症诱导的动脉粥样硬化进展。
要点
- HEG1是稳定血流诱导的内皮保护性基因,其缺失削弱稳定血流诱导的KLF2/4表达。
- 内皮HEG1敲除加重部分颈动脉结扎联合高胆固醇血症小鼠的晚期斑块及斑块内出血。
- 人晚期动脉粥样硬化斑块的冠状动脉内皮HEG1表达降低,提示其临床相关性。
核心结论
- HEG1是血流介导内皮保护性反应的新型介导因子,并可能是潜在治疗靶点。
研究设计与样本
- 研究设计包括小鼠部分颈动脉结扎模型的单细胞RNA测序数据再分析、人主动脉内皮细胞(HAEC)体外剪切实验、内皮特异性他莫昔芬诱导HEG1敲除(HEG1iECKO)小鼠模型。
- 动脉粥样硬化模型采用腺相关病毒-PCSK9注射联合西方饮食诱导高胆固醇血症,分别进行2周部分颈动脉结扎或2个月无手术。
主要发现
- 稳定血流在体内和体外均诱导HEG1的mRNA和蛋白表达,并促进HEG1蛋白向HAEC下游侧转位及释放至培养基。
- HEG1敲低阻止稳定血流诱导的内皮反应,包括单核细胞黏附、通透性和迁移。
- 机制上,HEG1敲低通过调控细胞内结合伙伴KRIT1及MEKK3-MEK5-ERK5-MEF2通路,阻止稳定血流诱导的KLF2/4表达。
- 与同窝对照相比,高胆固醇血症2周联合部分颈动脉结扎的HEG1iECKO小鼠形成晚期动脉粥样硬化斑块,特征为坏死核心面积增加、薄纤维帽粥样斑块、炎症和斑块内出血。
- 在2个月常规西方饮食模型中,HEG1iECKO小鼠在雌雄两性的动脉树及雄性的主动脉窦均显示动脉粥样硬化加重,但雌性主动脉窦无此现象。
临床怎么用
- HEG1及其下游KRIT1-MEKK3-MEK5-ERK5-MEF2-KLF2/4通路可能作为动脉粥样硬化防治的新靶点。
- 内皮HEG1表达降低与人类晚期斑块相关,提示其可作为斑块进展的生物标志物或干预靶点。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
BACKGROUND: Atherosclerosis preferentially occurs in arterial regions of disturbed blood flow, and stable flow (s-flow) protects against atherosclerosis by incompletely understood mechanisms. METHODS: Our single-cell RNA-sequencing data using the mouse partial carotid ligation model was reanalyzed, which identified Heart-of-glass 1 (HEG1) as an s-flow-induced gene. HEG1 expression was studied by immunostaining, quantitive polymerase chain reaction, hybridization chain reaction, and Western blot in mouse arteries, human aortic endothelial cells (HAECs), and human coronary arteries. A small interfering RNA-mediated knockdown of HEG1 was used to study its function and signaling mechanisms in HAECs under various flow conditions using a cone-and-plate shear device. We generated endothelial-targeted, tamoxifen-inducible HEG1 knockout (HEG1iECKO) mice. To determine the role of HEG1 in atherosclerosis, HEG1iECKO and littermate-control mice were injected with an adeno-associated virus-PCSK9 [proprotein convertase subtilisin/kexin type 9] and fed a Western diet to induce hypercholesterolemia either for 2 weeks with partial carotid ligation or 2 months without the surgery. RESULTS: S-flow induced HEG1 expression at the mRNA and protein levels in vivo and in vitro. S-flow stimulated HEG1 protein translocation to the downstream side of HAECs and release into the media, followed by increased messenger RNA and protein expression. HEG1 knockdown prevented s-flow-induced endothelial responses, including monocyte adhesion, permeability, and migration. Mechanistically, HEG1 knockdown prevented s-flow-induced KLF2/4 (Kruppel-like factor 2/4) expression by regulating its intracellular binding partner KRIT1 (Krev interaction trapped protein 1) and the MEKK3-MEK5-ERK5-MEF2 pathway in HAECs. Compared with littermate controls, HEG1iECKO mice exposed to hypercholesterolemia for 2 weeks and partial carotid ligation developed advanced atherosclerotic plaques, featuring increased necrotic core area, thin-capped fibroatheroma, inflammation, and intraplaque hemorrhage. In a conventional Western diet model for 2 months, HEG1iECKO mice also showed an exacerbated atherosclerosis development in the arterial tree in both sexes and the aortic sinus in males but not in females. Moreover, endothelial HEG1 expression was reduced in human coronary arteries with advanced atherosclerotic plaques. CONCLUSIONS: Our findings indicate that HEG1 is a novel mediator of atheroprotective endothelial responses to flow and a potential therapeutic target.
引用
- Tamargo IA, Baek KI, Xu C, et al. HEG1 Protects Against Atherosclerosis by Regulating Stable Flow-Induced KLF2/4 Expression in Endothelial Cells. Circulation. 2023. PMID: 38099436. doi:10.1161/CIRCULATIONAHA.123.064735
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。